DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Hortobagyi GN, Stemmer SM, Burris HA. et al.
Ribociclib as first-line therapy for HR-positive, advanced breast cancer.
N Engl J Med 2016;
375: 1738-1748 . doi:10.1056/NEJMoa1609709
We do not assume any responsibility for the contents of the web pages of other providers.